The Long-Term Clinical Outcomes of Combination Therapy withAngiotensin II Type 1 Receptor Blocker and Simvastatin after Percutaneous Coronary Intervention

참고문헌 (Reference)

1 "or both in myocardial infarction complicated by heartfailure" 1893-906

2 "Valsartanfor prevention of restenosis after stenting of type B2/Clesions:the VAL-PREST trial" 13 : 93-7, 2001

3 "Tissue angiotensin and pathobiology of vascular disease:a unifying hypothesis" 37 : 1047-52, 2001

4 "The comparison among lowand high doses of imidapril,and combined imidapril withlosartan in patients with ischemic heart failure after coronaryintervention" 30 : 965-72, 2000

5 "The clinical effects of acombined agent including losartan and hydrochlorthiazide,Hyzaar？？,in patients with ischemic heart failure" 32 : 349-54, J2002

6 "Statins do more thanjust lower cholesterol" 348 : 1079-82, 1996

7 "Statins as potent anti-inflammatory drugs" 106 : 2041-2, 2002

8 "Renoprotective effectof the angiotensin-receptor antagonist irbesartan in patientswith nephropathy due to type 2 diabetes" 345 : 851-60, 2001

9 "Prothrombotic effects of angiotensin" 45 : 419-29, 2000

10 "Prevention of cardiovascular events anddeath with pravastatin in patients with coronary heart diseaseand a broad range of initial cholesterol levels" 339 : 1349-57, Med1998

11 "Platelet glycoprotein IIIa polymorphism and risk of coronarystent thrombosis" 350 : 1217-9, 1997

12 "Lovastatin prevents angiotensinII-induced cardiac hypertrophy in cultured neonatal rat heartcells" 376 : 139-48, 1999

13 "Irbesartan,an angiotensin type 1 receptor inhibitor,regulates markers ofinflammation in patients with premature atherosclerosis" 37 : 440-4, 2001

14 "Inhibition of geranylgeranylationreduces angiotensin II-mediated free radicalproduction in vascular smooth muscle cells:involvement ofangiotensin AT1 receptor expression and Rac1 GTPase" 59 : 646-54, 2001

15 "Inhibition of early atherogenesis by losartan in monkeys withdiet-induced hypercholesterolemia" 101 : 1586-93, 2000

16 "Inflammation,pravastatin,and the risk of coronary events after myocardial infarctionin patients with average cholesterol levels" 98 : 839-44, 1998

17 "Hyperlipidemia and coronary disease:correction ofthe increased thrombogenic potential with cholesterol reduction" 92 : 3172-7, 1995

18 "Fluvastatinenhances the inhibitory effects of a selective angiotensinII type 1 receptor blocker,valsartan,on vascular neointimalformation" 107 : 106-12, 2003

19 "Evaluation of nine automatedhigh-sensitivity C-reactive protein methods" 47 : 418-25,

20 "Effects of simvastatin alone orcombined with ramipril on nitric oxide bioactivity and inflammationmarkers in hypercholesterolemic patients" 33 : 1053-9, 2003

21 "Effects of atorvastatinon early recurrent ischemic events in acute coronarysyndromes" 285 : 1711-8, 2001

22 "Effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients" 342 : 145-53, Med2000

23 "Effect of ramipril on mortality and morbidity of survivorsof acute myocardial infarction with clinical evidence of heartfailure" 821-8, lancet1993

24 "Effect of enalapril on mortality andthe development of heart failure in asymptomatic patients withreduced left ventricular ejection fractions" 327 : 685-91, 1992

25 "Effect of atorvastatinand irbesartan alone and in combination and inflammation in type2 diabetic patients" 2518-24, circulation2005

26 "Distinct and combinedvascular effects of ACE blockade and HMG-CoA reductase inhibitionin hypertensive subjects" 33 : 719-25, 1999

27 "Cholesterol reductionrapidly improves endothelial function after acute coronary syndromes" 99 : 3227-33, 1999

28 "Central role of the AT1-receptor in atherosclerosis" 16 (16): -33, 2002

29 "Cardiovascularmorbidity and mortality in the Losartan Intervention For Endpointreduction in hypertension study(LIFE)a randomised trialagainst atenolol" 359 : 995-1003, 2002

30 "Angiotensintype 1 receptor antagonism reverses abnormal coronary vasomotionin atherosclerosis" 38 : 1089-95, 2001

31 "Additive beneficial effects oflosartan combined with simvastatin in the treatment of hypercholesterolemic,hypertensive patients" 110 : 3687-92, 2004

32 "Acute and chronicangiotensin-1 receptor antagonism reverses endothelialdysfunction in atherosclerosis" 101 : 2349-54, 2000